Inhibition of topoisomerase II by ICRF-193, the meso isomer of 2,3-bis(2,6-dioxopiperazin-4-yl)butane-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of topoisomerase II by ICRF-193, the meso isomer of 2,3-bis(2,6-dioxopiperazin-4-yl)butane

Published:1996-08 Issue:4 Volume:52 Page:543-549
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Snapka Robert M.,Woo Sung Ho,Blokhin Andrei V.,Witiak Donald T.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference23 articles.

1. Topoisomerases and the swivel problem;Been,1980

2. SV40 DNA replication intermediates: Analysis of drugs which target mammalian DNA replication;Snapka;Bioessays,1993

3. DNA topoisomerase poisons as antitumor drugs;Liu;Ann Rev Biochem,1989

4. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives;Tanabe;Cancer Res,1991

5. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone;Drake;Cancer Res,1989

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo;Clinical Science;2021-08

2. Structure–Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ Interactions;Journal of Medicinal Chemistry;2021-03-22

3. Large-Scale Synthesis of Piperazine-2,6-dione and Its Use in the Synthesis of Dexrazoxane Analogues;Synthesis;2016-08-31

4. Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers;Cellular and Molecular Life Sciences;2014-11-28

5. Synthesis, characterization and metal chelating properties of silica-physisorbed and chemisorbed-2,5-dioxypiperazine;Polyhedron;2007-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3